GPC3 and neoplasm: The hYP7 mAb does not inhibit HCC tumor cell proliferation as it binds the C-terminal lobe of GPC3, while the N-terminal lobe of GPC3 is involved in Wnt/Frizzle binding, signaling, and HCC proliferation [21].